Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
Few with type 2 diabetes receive guideline-recommended CKD screening
Jul 01, 2024
24.9 percent received creatinine and UACR screening; Hispanic ethnicity associated with lack of screening
Timing of metformin important in metformin-treated type 2 diabetes
Jun 21, 2024
Glucose lowering is greater when metformin is given before rather than with enteral glucose; this is also linked to greater GLP-1 response.
Endocrine Society, June 1-4
Jun 20, 2024
The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.
Vitamin D suggested for children, seniors, those with high-risk prediabetes
Jun 10, 2024
No evidence was seen to support routine 25(OH)D screening in the general population.
Semaglutide cuts risk for kidney outcomes, death in CKD with T2DM
May 31, 2024
A reduction was seen in risk for clinically important kidney outcomes and death from cardiovascular causes.
Men face more diabetes complications than women
May 17, 2024
The findings were independent of diabetes duration over a 10-year period.
Eli Lilly says Zepbound can ease obstructive sleep apnea
Apr 17, 2024
Studies revealed that the medication reduced sleep apnea severity by nearly two-thirds.
Nerve decompression may ease painful diabetic peripheral neuropathy
Mar 28, 2024
Nerve decompression was associated with reduced pain, but equal improvement was seen in decompressed and sham legs.
Diabetes complications more common in patients not living in urban areas
Mar 27, 2024
The findings were seen for residents of remote areas and small towns compared with those living in cities.